1259020-46-6

Basic information

• Product Name: 5-bromo-2-chloro-4-hydroxybenzonitrile
• Synonyms: 5-bromo-2-chloro-4-hydroxybenzonitrile
• CAS NO: 1259020-46-6
• Molecular Weight: 232.464
• Mol File: 1259020-46-6.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 5-bromo-2-chloro-4-hydroxybenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-chloro-4-hydroxybenzonitrile(1259020-46-6)
• EPA Substance Registry System: 5-bromo-2-chloro-4-hydroxybenzonitrile(1259020-46-6)

Safety Data

• Hazardous Substances Data: 1259020-46-6(Hazardous Substances Data)

Upstream product

• 3336-16-1 2-chloro-4-hydroxybenzonitrile 

Downstream Products

• 1259020-79-5 5-bromo-2-chloro-4-methoxybenzonitrile 
• 1259020-48-8 5-bromo-2-chloro-4-methoxybenzoic acid 
• 1313513-17-5 (2S,3R,4R,5S,6R)-2-(2-(allyloxy)-4-chloro-5-((5-(4-fluorophenyl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-16-4 (2S,3R,4R,5S,6R)-2-(2-(allyloxy)-4-chloro-5-((5-phenylthiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-15-3 (2S,3R,4R,5S,6R)-2-(2-(allyloxy)-4-chloro-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-14-2 (2S,3R,4R,5S,6R)-2-(2-(allyloxy)-4-chloro-5-((5-(thiophen-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-13-1 (2S,3R,4R,5S,6R)-2-(2-(allyloxy)-4-chloro-5-((5-(furan-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-12-0 (2S,3R,4R,5S,6R)-2-(2-allyloxy-4-chloro-5-((5-(furan-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-11-9 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-(4-fluorophenyl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-10-8 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-phenylthiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-09-5 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-08-4 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-(thiophen-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-07-3 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-(furan-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-06-2 (2S,3R,4R,5S,6R)-2-(4-chloro-2-ethoxy-5-((5-(furan-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 

Relevant articles and documents

Discovery of GCC5694A: A potent and selective sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes

Sodium-dependent glucose co-transporter 2 (SGLT2) has emerged as a promising drug target for the treatment of type 2 diabetes, and recently, several SGLT2 inhibitors have been approved for clinical use. A series of molecules with a C-aryl glucoside scaffo

FURANE DERIVATIVES AS INHIBITORS OF ATAD2

The invention relates to fur an e derivatives of formula (I) as inhibitors of ATAD2, a process for their preparation and use thereof.

Novel macrocyclic C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents

Novel macrocyclic C-aryl glucoside SGLT2 inhibitors were designed and synthesized. Two different synthetic routes of macrocyclization were adopted to prepare novel ansa SGLT2 inhibitors. Among the compounds tested, [1,7]dioxacyclopentadecine macrocycles p